Evidence map›Paper›PMID 38282193›Full record

ArticleClinical and translational allergy2024

Exploring the role of information and communication technologies in allergic rhinitis in specialist centers: Patient perspectives on usefulness, value, and impact on healthcare.

Ivan Cherrez-Ojeda, Jean Bousquet, Zouina Sarfraz, Azza Sarfraz, Monica Rodriguez Gonzales, Anna Bedbrook, Nelson Rosario, Benjamin Zepeda-Ortega, Guillermo Guidos, Ulbio Alcivar Molina and 5 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational allergy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 7 countries.

Ivan Cherrez-OjedaUniversidad Espíritu Santo, Samborondón, Ecuador.ORCID https://orcid.org/0000-0002-1610-239X
Jean BousquetInstitute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-4061-4766
Zouina SarfrazResearch and Publications, Fatima Jinnah Medical University, Lahore, Pakistan.
Azza SarfrazPediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Monica Rodriguez GonzalesUrticaria Center of Reference and Excellence (UCARE), Department of Allergy, Hospital Español de México, Mexico City, Mexico.
Anna BedbrookARIA & MASK-air, Montpellier, France.
Nelson RosarioHospital de Clinicas, University of Parana, Parana, Brazil.
Benjamin Zepeda-OrtegaPediatric Allergist Private Practice, Angeles Lomas Hospital Huixquilucan Mexican State, Mexico City, Mexico.
Guillermo GuidosDepartment of Immunology, School of Medicine, Instituto Politecnico Nacional, Gustavo A. Madero, CDMX, Mexico City, Mexico.
Ulbio Alcivar MolinaHospital Luis Vernaza, Servicio de Otorrinolaringología, Guayaquil, Ecuador.
Miguel FelixUniversidad Espíritu Santo, Samborondón, Ecuador.ORCID https://orcid.org/0000-0002-2243-3646
Emanuel VanegasUniversidad Espíritu Santo, Samborondón, Ecuador.
Karla Robles-VelascoUniversidad Espíritu Santo, Samborondón, Ecuador.
Luc J ZimmermannSchool for Oncology & Developmental Biology (GROW), University of Maastricht, Maastricht, Netherlands.
Antonio W D GavilanesSchool for Oncology & Developmental Biology (GROW), University of Maastricht, Maastricht, Netherlands.
Universidad de Especialidades Espíritu Santo · ECAga Khan University · PKAirbus (France) · FRFatima Jinnah Medical University · PKHospital de Clínicas Universidade Federal do Paraná · BRHospital Español · MXHospital Luis Vernaza · ECHumboldt-Universität zu Berlin · DEInstituto Politécnico Nacional · MXMaastricht University · NLMexican Geological Survey · MXUniversidad Católica de Santiago de Guayaquil · EC

Funding

Universidad Espiritu Santo, Ecuador Grant #2021-MED-002
6 · The paper itself

Abstract

introductionInformation and communication technologies (ICTs) improve patient-centered care and are routinely used in Allergic Rhinitis (AR), but patients' preferences and attitudes are unexplored. This study examines AR-related information preferences and ICT use by AR patients.

methodsA survey-based cross-sectional study was carried out in Ecuador from July to September 2019 in seven centers of reference for allergic disease. Participants were 18 years or older, diagnosed with AR and had access to ICT and the Internet. Descriptive and binomial logistic regressions were performed. A value of less than 0.05 was considered statistically significant.

results217 patients were included. 47% (n = 102) used ICTs to learn about AR, of which 38.2% (n = 83) found it useful. Most of participants (75%, n = 164) did not think that ICTs reduce their need to see a doctor. Individuals with poorer quality of life were more likely to utilize ICTs to contact their doctor (OR 1.27, 95% CI 1.04-1.55), and more likely to be interested in AR-related content (OR 1.23, 95% CI 1.00-1.52). Patients with long-term AR or other allergies were less likely to use ICTs (OR 0.92 and OR 0.40 respectively). Higher education and lower quality of life may increase AR apps adoption (OR 4.82, 95% CI 1.11-21.00). Academic preparation five-fold increased ICT use for health provider communication (OR 5.29, 95% CI 1.18-23.72). Mild-persistent AR enhanced the probabilities of using ICTs to share experiences and communicate with other patients (OR 12.59, 95% CI 1.32-120.35).

conclusionsOur study emphasizes the importance of tailoring digital resources to patient needs by considering factors such as quality of life, education, and specific subgroups within the AR patient population. Additionally, the findings suggest that while ICTs can play a valuable role in patient education and support, they should complement, rather than replace, traditional medical care for many AR patients.

Indexed as

allergic rhinitisEcuadorinformation and communication technologies

Identifiers

PMID38282193
PMCPMC10799206
OpenAlexW4391053811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.